Your browser doesn't support javascript.
loading
Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.
Merdan, Selin; Tomlins, Scott A; Barnett, Christine L; Morgan, Todd M; Montie, James E; Wei, John T; Denton, Brian T.
Afiliación
  • Merdan S; Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan.
  • Tomlins SA; Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Barnett CL; Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Morgan TM; Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan.
  • Montie JE; Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Wei JT; Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan.
  • Denton BT; Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan.
Cancer ; 121(22): 4071-9, 2015 Nov 15.
Article en En | MEDLINE | ID: mdl-26280815
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Serina Endopeptidasas / Transactivadores / Fusión Génica / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Serina Endopeptidasas / Transactivadores / Fusión Génica / Antígenos de Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Año: 2015 Tipo del documento: Article